-
the side effects that are often seen with classical cancer drugs? Over the years there have been a number of approaches to developing targeting methods. We have previously used peptides to generate molecules
-
Project supervisor - Dr Tom Hargreaves Tackling climate change and meeting Net Zero targets will demand substantial changes to people’s everyday lives. Many different visions of Net Zero energy
-
neuroprotective effects. Camptothecin – A clinically relevant anticancer agent targeting Topoisomerase I. In collaboration with Prozomix Ltd. (an industrial leader in enzyme development), this project will
-
that underpin immune recognition by these proteins, and how they could be engineered to expand or otherwise improve their use in agriculture. Our target for developing new disease resistance is the most
-
the PhD student to propose targets to preserve liver metabolic health and prevent disease progression associated to poor dietary habits, which will be investigated in this project. This collaborative
-
interventions. These insights may ultimately lead to the identification of new targets for the development of therapies for ageing and age-related disease. For more information please contact: rebecca.c.taylor